XLO
Xilio Therapeutics Inc · NASDAQ NMS - GLOBAL MARKET · Biotechnology
$8.52+$0.06 (+0.71%)
Prices delayed up to 5 minutes
AC Intelligence
AC Intelligence
AC Intelligence for XLO is being prepared.
Key Stats
Key Stats
Open
$8.44
Day High
$8.73
Day Low
$8.20
Prev Close
$8.46
Volume
0
Avg Volume
50.8K
Day Change
+$0.06
Change %
+0.71%
Fundamentals
Fundamentals
P/B
0.95
EPS (TTM)
$-5.41
Market Cap
$49M
52-Wk Range
$6.47 — $16.52
Who Owns This Stock
Who Owns XLO
Other90.5%27 holders
Passive / Index4.0%3 holders
Dealer / Bank2.3%4 holders
Quality / Compounder1.3%1 holder
Tactical / Macro1.1%1 holder
Systematic / Quant0.9%1 holder
Based on Q4 2025 13F filings + AC behavioral model
37 institutional holders
Top Holders
0.0%$5829.3B
+61.4%$4720.0B
$3786.8B
$2560.8B
$1366.5B
$1299.6B
0.0%$949.9B
$757.4B
$712.7B
$698.6B
$537.7B
0.0%$427.5B
0.0%$327.7B
$279.3B
+68.3%$220.5B
+370.8%$172.9B
$119.3B
$108.8B
$103.2B
$80.8B
Institutional Pressure
Market Regime:Strong Risk-Off (-0.62)SELLINGBUYING
▲
Mild Selling Pressure
Other(90.5%)
●
—Passive / Index(4.0%)
●
HoldsDealer / Bank(2.3%)
●
FacilitatingQuality / Compounder(1.3%)
●
Holds throughTactical / Macro(1.1%)
●
Reducing rapidlySystematic / Quant(0.9%)
●
De-risking (mechanical)5% passive + quality floor won't sell.
Updated daily · Based on Q4 2025 filings + AC behavioral model
Sentiment Signals
Sentiment Signals
→Insider ActivityNo insider transactions in last 90 daysSEC Form 4
↑Analyst Consensus4 buy, 1 hold, 0 sellFinnhub
↑↑Inst. Flows29 increased/new, 2 decreased/exited (13F)AC 13F Analysis
Sources: SEC Form 4, Finnhub, AC 13F Analysis
On AcidCapitalist
On AcidCapitalist
No recent mentions of XLO on AcidCapitalist.
Data provided by Finnhub. Prices delayed up to 5 minutes.